Novartis registers new Phase IIIb IgAN trial and VEXAS Phase 2; gMG trial still activeSep 30Weekly roundup, 7 itemsarumakimigatrasentanUpdated
Novartis updates Zortress label; advances Fanconi anemia and IgAN trialsSep 16Weekly roundup, 4 itemsatrasentaneltrombopag
Novartis posts ASSIST Phase 2 results; two pediatric studies listedJul 21Weekly roundup, 3 itemsatrasentancoartem baby
Sign inSign in